The RADV Audit Landscape
Between 2024 and 2025, the HHS Office of Inspector General (OIG) published Risk Adjustment Data Validation (RADV) audit findings for 10 Medicare Advantage organizations. These audits examined whether MA plans submitted accurate diagnosis codes to CMS — the codes that determine how much the federal government pays each plan per enrollee.
The findings were consistent across every plan: 70–99% of sampled high-risk diagnosis codes were unsupported or miscoded, resulting in millions of dollars in estimated overpayments per organization.
With Medicare Advantage now covering approximately 45% of all Medicare payments, accurate risk adjustment is a major federal financial priority. These audits are not one-off events — they are part of a systematic OIG enforcement series targeting the same high-risk diagnosis categories across plans nationwide.
Every audited plan followed the same structure: stratified random sampling by diagnosis group, independent medical review, and findings broken down by high-risk diagnosis category. All 10 plans received the same three recommendations: refund overpayments, self-identify similar errors, and improve compliance procedures. All 10 disagreed.
Key Findings at a Glance
Across the 10 audited plans, four metrics define the scale of the problem:
Near-Universal Miscoding: Acute Stroke (99%), Colon Cancer (98%), Acute MI (96%) — error rates so high they signal systemic coding failures across the industry, not isolated chart-level mistakes.
Highest Dollar Exposure Per Enrollee: Lung Cancer ($5,937/yr) and Ovarian Cancer ($5,242/yr) carry 3–6x the financial risk of other categories. Together, cancer diagnoses account for 62% of all audit overpayments.
All 12 Diagnosis Categories Under OIG Scrutiny
OIG targeted the same high-risk diagnosis groups across plans. The consolidated table below ranks all 12 audited categories by average overpayment per enrollee-year — the most direct measure of financial exposure per finding.
| Diagnosis | Plans | Sample | Errors | Error Rate | Overpayment | $/Yr |
|---|---|---|---|---|---|---|
| Lung Cancer Cancer | 8 | 251 | 229 | $1,491,091 | $5,941 | |
| Ovarian Cancer Cancer | 2 | 60 | 58 | $314,520 | $5,242 | |
| Pressure Ulcer Non-Cancer | 3 | 83 | 29 | $215,925 | $2,601 | |
| Embolism Non-Cancer | 8 | 240 | 199 | $528,087 | $2,200 | |
| Colon Cancer Cancer | 8 | 240 | 234 | $523,501 | $2,181 | |
| Acute Stroke Non-Cancer | 8 | 240 | 238 | $435,421 | $1,814 | |
| Acute MI Non-Cancer | 8 | 240 | 231 | $386,008 | $1,608 | |
| Sepsis Non-Cancer | 5 | 170 | 69 | $190,219 | $1,119 | |
| Breast Cancer Cancer | 8 | 240 | 229 | $287,528 | $1,198 | |
| Prostate Cancer Cancer | 8 | 240 | 211 | $250,049 | $1,042 | |
| Vascular Claudication Non-Cancer | 1 | 30 | 3 | $3,739 | $125 | |
| Major Depressive Disorder Non-Cancer | 1 | 30 | 1 | $1,998 | $67 |
Error Rate by Diagnosis Category
Visualizing error rates highlights the distinction between near-universal miscoding (cancers and acute conditions) and selectively flagged categories (Sepsis, Pressure Ulcer):
Cancer Non-Cancer · Vascular Claudication (10%) and Major Depressive Disorder (3%) omitted
Plan-Level Audit Exposure
While error patterns are consistent across plans, the financial exposure varies significantly based on plan size and enrollee universe. Below are the 10 audited organizations and their estimated overpayments:
| Organization | Sample Non-Compliant | Estimated Overpayment |
|---|---|---|
| MMM Healthcare | 44% (87/200) | $59M |
| Humana Health Plan | 84% (202/240) | $13.1M |
| Independent Health | 93% (230/247) | $7.0M |
| Coventry Health | 83% (249/300) | $6.9M |
| BCBS Michigan | 91% (192/210) | $6.4M |
| EmblemHealth | 67% (134/200) | $130.7M* |
| UCare Minnesota | 86% (254/294) | $4.7M |
| Health Assurance | 83% (222/269) | $4.3M |
| MediGold | 90% (189/210) | $3.7M |
| Triple-S Advantage | 73% (204/281) | $297K* |
* Triple-S Advantage amount is not extrapolated in the published report. * EmblemHealth uses HCC-level audit methodology (differs from diagnosis-group approach used by other plans); figure not directly comparable.
Cancer vs. Non-Cancer: Where the Money Is
Cancer diagnoses dominate the financial exposure in RADV audits. Understanding this split is critical for prioritizing remediation efforts.
Cancer Diagnoses
Non-Cancer Diagnoses
Cancer Category Breakdown
| Cancer Type | Plans | Sample | Errors | Error Rate | Overpayment | Avg $/Yr |
|---|---|---|---|---|---|---|
| Lung Cancer | 8 | 251 | 229 | 91% | $1,491,091 | $5,941 |
| Ovarian Cancer | 2 | 60 | 58 | 97% | $314,520 | $5,242 |
| Colon Cancer | 8 | 240 | 234 | 98% | $523,501 | $2,181 |
| Breast Cancer | 8 | 240 | 229 | 95% | $287,528 | $1,198 |
| Prostate Cancer | 8 | 240 | 211 | 88% | $250,049 | $1,042 |
| All Cancers | — | 1,031 | 961 | 93% | $2,866,689 | $2,780 |
The Single Biggest Lever: Lung Cancer alone drives 52% of cancer overpayments ($1.49M of $2.87M) despite having a similar sample size to other categories. It is both the highest-cost and most consistently audited category — present in every future RADV audit with near-certainty.
Non-Cancer Category Breakdown
| Diagnosis | Plans | Sample | Errors | Error Rate | Overpayment | Avg $/Yr |
|---|---|---|---|---|---|---|
| Pressure Ulcer | 3 | 83 | 29 | 35% | $215,925 | $2,601 |
| Embolism | 8 | 240 | 199 | 83% | $528,087 | $2,200 |
| Acute Stroke | 8 | 240 | 238 | 99% | $435,421 | $1,814 |
| Acute MI | 8 | 240 | 231 | 96% | $386,008 | $1,608 |
| Sepsis | 5 | 170 | 69 | 41% | $190,219 | $1,119 |
| Vascular Claudication | 1 | 30 | 3 | 10% | $3,739 | $125 |
| Major Depressive Disorder | 1 | 30 | 1 | 3% | $1,998 | $67 |
| All Non-Cancers | — | 1,033 | 770 | 75% | $1,761,397 | $1,705 |
Cardiovascular Is the Second Priority: Embolism and Acute Stroke together contribute $964K in sample overpayments — more than Breast and Prostate Cancer combined — making cardiovascular diagnoses the clear second priority for payor remediation after cancer.
Error Rate vs. Dollar Risk: They Don't Always Align
A high error rate does not automatically mean high financial risk — and vice versa. Understanding this distinction is essential for prioritizing remediation efforts:
Lung Cancer, Ovarian Cancer
Maximum financial risk. Top priority for immediate remediation. Every unsupported code is expensive and nearly every code is unsupported.
Pressure Ulcer
Documentation is harder but defensible when done right. Only 35% error rate but $2,601/enrollee. Worth targeted investment in documentation quality.
Acute Stroke, Colon Cancer
Volume problem. 98–99% error rates suggest systemic miscoding — not isolated cases. Operationally the easiest fix through process correction.
Sepsis, Vascular Claudication
Lower immediate priority, but Sepsis is expanding into standard audit batteries. Build protocols now before it becomes a universal target.
The 11x Extrapolation Multiplier
The most important financial dynamic in RADV audits is not the sample error — it's the extrapolation. OIG doesn't just recover overpayments found in the sample. It extrapolates findings to the entire enrollee universe.
This means pre-submission validation doesn't just prevent the face-value error — it prevents the amplified penalty. A single Lung Cancer code corrected before submission doesn't save $5,937. With the 11x multiplier, it saves approximately $65,000 in extrapolated penalty exposure.
The Only Free Intervention Point: Once a diagnosis code is submitted to CMS and flagged in an OIG audit, a plan's options are limited: repay or dispute — both costly. Pre-submission validation is the only moment where correction is cost-free. Clean data goes to CMS. Flagged data goes back for resolution. No audit. No penalty. No dispute.
How RADV Scrubber Works
RADV Scrubber is a rules engine that processes member data through automated clinical, demographic, and service validation — surfacing discrepancies before CMS submission. It is part of the Precise Health Risk Compass platform.
Access Member Data
Prior-year claims (IP/OP/Rx), MA04 & MOR — or live encounter data (837P/837I)
Extract & Scrub
Each member flows through the RADV Scrubber REST API for fast, automated rules-based validation
Analyze & Detect
Rules engine validates clinical, demographic, and service data across 60+ high-risk condition groups
Flag & Prioritize
Discrepancies surfaced with finding comments; targeted chase lists ranked by RAF score impact
Resolve & Submit
Coders and auditors resolve flags; clean, validated data submitted to CMS EDPS/RAPS
Dual Workflow Integration
RADV Scrubber supports both workflow models — catching errors at the point of encounter submission and during retrospective review:
Concurrent Workflow
Flags encounter data before Claims Processing & CMS EDPS/RAPS submission.
Retrospective Workflow
Reviews prior-year data and outputs Supplemental Data or Chart Review Records.
60+ High-Risk Condition Groups • 7,000+ HCC-Associated ICDs • 20+ Validation Types • REST API • HIPAA Compliant • ISO 27001:2022
What RADV Scrubber Validates
Three validation dimensions — clinical accuracy, demographic consistency, and service pattern verification — across all OIG/CMS-audited HCC categories and beyond.
Clinical Data
Dx code rules, acute vs. history status, cancer/mental health/end-stage classification; labs, radiology, medications & therapeutic validation; anatomical conflicts & ICD-10 guideline checks
Demographic Data
Missing/mismatched member & provider specialties; gender conflicts, age-based condition checks; date-of-service overlaps and enrollment validation
Service Data
Place of service, visit frequency, provider specialty checks; mutually exclusive & conflicting diagnosis code detection
Audit Finding → RADV Scrubber Capability
Every OIG audit finding maps directly to a RADV Scrubber capability. The same errors flagged after the fact by OIG are caught before submission:
ICD-10 Guideline Auditor
Complementing RADV Scrubber, the ICD-10 Guideline Auditor provides automated ICD-10 coding guideline validation — embedded directly in your HCC coding workflow, surfacing errors before submission.
100% ICD-10 VALIDATION IN SECONDS
Automates 100% of ICD-10 coding guideline validation during HCC coding. Every code validated instantly — before claim submission.
- Code First, Use Additional Code, Excludes1 & Specificity checks
- Laterality, Severity, and Combination Code validation
- Gender, End-Stage, Historical vs. Active conflict detection
- Intelligent code suggestions — surfaces new revenue opportunities
- Up to 50% improvement in auditor efficiency via REST API
What RADV Scrubber Can Save Your Plan
The only cost-free intervention is catching errors before CMS submission. Every avoided error prevents approximately 11x its value in extrapolated penalties.
Savings by Diagnosis Priority
If a plan focuses RADV Scrubber specifically on the highest-exposure categories:
| Focus Area | Total Overpayment (10 Plans) | Savings at 75% |
|---|---|---|
| All categories | $4,628,086 | $3.5M |
| Cancers only | $2,866,689 | $2.1M |
| Non-cancers only | $1,761,397 | $1.3M |
| Lung Cancer alone | $1,491,091 | $1.1M |
Sample overpayments above are from 210–300 enrollee-year samples. Extrapolated to full plan populations, these figures scale 10–15x.
Strategic Recommendations for Payors
Based on the OIG findings across all 10 audited plans, here are prioritized actions for Medicare Advantage organizations:
Immediate: Audit Your Highest-Exposure Categories
Audit your own Lung Cancer, Ovarian Cancer, and Embolism records before OIG does. These carry $2,196–$5,937 per enrollee-year and have 83–97% error rates. Every unsupported code is a significant financial liability.
Systematic: Fix Process-Level Coding Failures
Acute Stroke (99%) and Colon Cancer (98%) error rates indicate process failures, not individual chart problems. Implement automated pre-submission validation to catch these systematic miscoding patterns at scale.
Proactive: Prepare for Expanding Audit Scope
Sepsis and Pressure Ulcer appeared in only 3–5 plans today but are being phased into standard audit batteries. Build documentation protocols now — before they become universal targets in all plans.
Ongoing: Ensure Record Retrievability
Several plans lost audit cases purely due to missing medical records — not wrong codes. Ensure records are retrievable, complete, and linked to submitted diagnosis codes.
The Core Six Are Unavoidable: Acute Stroke, Acute MI, Lung/Breast/Colon/Prostate Cancer, and Embolism appeared in 8 of 10 plans with 30 samples each — these are OIG's standard battery. Every MA plan should assume these categories will be audited. There is no avoiding them.
Lung Cancer: Plan-by-Plan Audit Data
As the single highest-cost diagnosis category, Lung Cancer warrants a detailed plan-by-plan breakdown. The consistency of findings across 8 plans underscores the systemic nature of the problem.
| Plan | Sample | Errors | Error Rate | Overpayment | $/Enrollee |
|---|---|---|---|---|---|
| UCare Minnesota | 30 | 29 | 97% | $238,858 | $7,962 |
| BCBS Michigan | 30 | 29 | 97% | $209,565 | $6,986 |
| Independent Health | 30 | 30 | 100% | $207,261 | $6,909 |
| Health Assurance | 30 | 26 | 87% | $197,559 | $6,585 |
| Coventry Health | 30 | 24 | 80% | $181,489 | $6,050 |
| Humana | 30 | 26 | 87% | $169,675 | $5,656 |
| MediGold | 30 | 28 | 93% | $169,417 | $5,647 |
| Triple-S Advantage | 41 | 37 | 90% | $117,267 | $2,860 |
| Total / Average | 251 | 229 | 91% | $1,491,091 | $5,941 |
References
HHS OIG Reports — Medicare Part C (Medicare Advantage)